Pharmacist-Led Patient Self-Testing Superior to Usual Care for Warfarin Management in Mechanical Heart Valve Patients: Evidence from a Multicentre RCT in China
Highlights
- Pharmacist-led patient self-testing (PST) achieved a significantly higher Time in Therapeutic Range (TTR) of 67.2% compared to 55.1% in usual care (p<0.001).
- The PST model reduced the incidence of major bleeding from 7.9% to 0.7% and thromboembolic events from 6.8% to 0.4%.
- Younger age and the use of the PST model were identified as independent protective factors against warfarin-related adverse events.
- The study demonstrates the feasibility and safety of decentralizing anticoagulation management in developing healthcare regions through pharmacist-led interventions.
Background: The Challenge of Warfarin Management in China
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.